Aptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Molecular Biology

Background:

• DNA's versatility enables nanoscale construction.
• DNA nanodevices offer programmability and functionalization for biological applications.
• Aptamers are key targeting and therapeutic moieties.

Purpose of the Study:

• Review recent advancements in aptamer-functionalized DNA nanodevices.
• Discuss their role as theranostic agents in cancer.
• Highlight challenges and solutions for clinical translation.

Main Methods:

• Literature review of DNA nanodevices and aptamer applications.
• Analysis of characterization techniques for DNA nanodevices.
• Examination of case studies in cancer diagnosis and therapeutics.

Main Results:

• Aptamer-functionalized DNA nanodevices demonstrate significant potential in cancer theranostics.
• These nanodevices serve as effective platforms for targeted drug delivery and imaging.
• Successful functionalization includes imaging, targeting, drug conjugation, and triggered release.

Conclusions:

• Aptamer-DNA nanodevices are promising for cancer diagnosis and therapy.
• Further research is needed to overcome challenges for clinical translation.
• Development of robust and scalable manufacturing processes is crucial.